雷纳酶通过PMCA4b/cAMP在NCI-H295R细胞中刺激阿尔多素的产生
Ru Fu1, Miao Huang1,2, Tao Liu1
1Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Journal of enzyme inhibition and medicinal chemistry
|January 7, 2026
概括
雷纳酶 (RNLS) 通过激活cAMP/PKA信号,显著增加了上腺细胞中阿尔多素的产生. 这种酶与PMCA4b结合,促进阿尔多素分泌,并可能导致相关疾病.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 雷纳酶 (RNLS) 是一种依赖于flavin adenine dinucleotide的单氨酸氧化酶,与相邻的上腺体相比,在生产阿尔多素的腺瘤 (APA) 中发现的水平更高.
- 对于RNLS在 adrenocortical细胞内调节 aldosterone 生产中的确切作用,目前还没有得到很大程度的描述.
研究的目的:
- 为了研究RNLS对上皮细胞中阿尔多素产生的影响.
- 阐明RNLS介导的阿尔多斯特合成调节背后的分子机制.
主要方法:
- 用RNLS对 adrenocortical细胞进行治疗,以评估对阿尔多素生产和细胞增殖的影响.
- 测量了关键类固醇酶 (HSD3B2,CYP21A2,CYP11B2) 的mRNA表达.
- 分析了包括cAMP/PKA在内的信号通路和转录因子激活.
- 使用免疫光和免疫沉进行了细胞表面受体结合和功能测定,包括siRNA敲除PMCA4b.
主要成果:
- 在不影响细胞增殖的情况下,RNLS上调了阿尔多斯特的产生.
- RNLS增加了HSD3B2,CYP21A2的mRNA表达,并显著刺激了CYP11B2.2.
- RNLS激活了cAMP/PKA信号通路,导致NR4A2的上调和ATF/CREB家族成员的酸化.
- 与细胞膜受体PMCA4b结合的RNLS;抑制PMCA4b抑制了RNLS诱导的阿尔多素产生.
结论:
- 在上腺皮层细胞中,RNLS充当了前激素因子.
- 该机制涉及RNLS与PMCA4b结合,激活cAMP/PKA信号,并随后影响类固醇酶表达.
- RNLS可能在阿尔多斯特介导疾病的发病过程中发挥作用.
相关概念视频
Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K


